Orthovita, Inc. (VITA)

[surf1944]

8:17AM Orthovita provides 24-month data from Cortoss clinical pilot studies in Vertebroplasty and Kyphoplasty (VITA) 1.85 : Co announces publication of "Clinical Experience Using Cortoss for Treating Vertebral Compression Fractures with Vertebroplasty and Kyphoplasty" in the 9/15/10 edition of Spine. The paper concludes that based on the results of these pilot studies: Cortoss is safe and effective in treating osteoporotic VCFs using either vertebroplasty or kyphoplasty and VCF pain relief and functional restoration achieved with Cortoss is comparable to the results reported in the literature for VCFs treated with polymethylmethacrylate.